Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Palliative Care
•
Critical Care
•
Hospital Medicine
Do you prefer scopolamine patches, glycopyrrolate, or other treatment regimens to manage oral secretions at the end of life?
Related Questions
When do you recommend starting a continuous opioid infusion for symptom control at the end of life?
At what point should you consider deactivating ICDs or implanted pacemakers in patients nearing the end of life but not imminently dying?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
How do you approach caring for patients admitted with decompensated CHF, but who also exhibit hypotension and do not have overt signs of hypervolemia on exam?
What do you think about using conventional thoracic imaging methods (e.g., X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?
How do you recommend incorporating B-lines on lung POCUS as part of evaluating a patient's volume status?
Under what circumstances do you recommend POCUS guidance for lumbar puncture?
Do you administer prophylactic antibiotics to prevent VAP following intubation in patients with acute brain injury?
Would you recommend starting tolvaptan at 7.5 mg per day, which is half the typical starting dose, to reduce the risk of overcorrection in an inpatient with SIADH and a serum sodium level of 122 mEq/L?
What are the logistical challenges and time constraints of implementing NIV for pre-oxygenation in emergency settings compared to oxygen masks?
